RegenerativeTreatment Guide
  • Conditions
  • Locations
  • How It Works
  • About
  • Blog
  • For Providers
  • Cost Calculator
  • Free Assessment
(888) 540-7505
  1. Home
  2. Conditions
  3. Stem Cell Therapy for Arthritis
Conditions

Stem Cell Therapy for Arthritis & Osteoarthritis: What the Research Says

How regenerative injections are being studied for osteoarthritis and joint inflammation — the mechanism, the evidence by joint, and how it compares to other options.

Conditions  ·  By the Regenerative Treatment Guide Editorial Team  ·  Updated September 28, 2026  ·  11 min read

Does stem cell therapy work for arthritis?

For knee osteoarthritis, the best current evidence says it can modestly reduce pain and improve function for at least a year. A 2025 meta-analysis of 8 randomized trials found that result, with no more side effects than control treatments. Evidence for the hip and shoulder is earlier-stage. For rheumatoid arthritis, benefits in trials so far haven't lasted past about 12 months.

It is not a proven cure, it doesn't reliably regrow cartilage, and it isn't FDA-approved for arthritis. The major osteoarthritis treatment guidelines still recommend against stem cell injections until larger trials are in.

Arthritis is one of the most common reasons people explore regenerative medicine — and also one of the most misunderstood. Online ads often promise that stem cells will "regrow your cartilage" and reverse arthritis. The reality, based on the research, is more nuanced and more honest: regenerative injections are an actively studied, investigational option that may help some people manage pain and inflammation, but they are not a guaranteed cure and they do not reliably rebuild a worn-out joint. This guide explains what arthritis is, how stem cell therapy is thought to work, what the evidence actually shows by joint, who may be a candidate, and the questions worth asking.

Understanding arthritis & osteoarthritis

"Arthritis" simply means joint inflammation, and there are many types. The most common — and the one most relevant to regenerative injections — is osteoarthritis (OA), the "wear-and-tear" form. In OA, the smooth cartilage that cushions the ends of the bones gradually breaks down. As that cushion thins, the joint becomes inflamed and you feel stiffness, swelling, and pain that often worsens with activity or after rest. OA can affect the knee, hip, shoulder, hands, spine, and other joints, and it's a leading cause of disability in adults.

It's worth distinguishing OA from inflammatory or autoimmune arthritis such as rheumatoid arthritis, which is driven by the immune system attacking the joints and is managed primarily with medications by a rheumatologist. Most regenerative injection research focuses on osteoarthritis, not autoimmune disease.

How is stem cell therapy thought to work for arthritis?

This is the most important — and most misrepresented — part. Much of the scientific interest in mesenchymal stem cells (MSCs) for arthritis centers on their anti-inflammatory and immunomodulatory signaling, not on wholesale tissue regrowth. In other words, MSCs appear to influence the joint environment — calming inflammation and releasing growth-signaling factors — rather than reliably rebuilding lost cartilage.

This helps explain a pattern researchers and clinicians often observe: some patients report relief even when imaging shows limited structural change. It also explains why "guaranteed cartilage regrowth" claims should be viewed skeptically — the evidence does not support promising that arthritis will be reversed. MSCs for the joint generally come from one of three sources: bone marrow (BMAC), adipose (fat) tissue, or umbilical cord tissue (Wharton's jelly) processed in an FDA-registered lab. Learn more in our complete guide to stem cell research.

What does the research show, by joint?

The depth of evidence differs a lot by joint. Thousands of studies are indexed on PubMed, with hundreds of trials on ClinicalTrials.gov, but quality and quantity vary:

  • Knee OA: the most studied. A 2025 meta-analysis of 8 randomized controlled trials (502 patients) looked only at stem cell injections given on their own, in knees that hadn't had surgery. Compared with control treatments, the injections improved pain and function scores at 6 and 12 months, with no significant difference in side effects. The improvements were modest in size, and the authors found adipose (fat-derived) cells and higher doses did better. An earlier 2021 meta-analysis of nine randomized trials reached a similar, cautious conclusion. See our knee pain guide.
  • Hip OA: promising but lower-quality evidence. A 2024 systematic review found 10 studies (316 patients) reporting better pain and function with few adverse events. The studies varied widely in design, and few were high quality. See our hip pain guide.
  • Shoulder OA: very limited. Most shoulder research is on rotator cuff tendons rather than shoulder arthritis. See our shoulder pain guide.
  • Other joints (hands, ankle, spine facets): earlier-stage and more limited evidence.

What the treatment guidelines say

Here's the part clinic websites rarely mention. A 2023 review of hip and knee osteoarthritis guidelines found that the higher-quality guidelines consistently recommend against stem cell injections for hip and knee OA. Instead they recommend exercise, education, weight management, anti-inflammatory medication, and (for the knee) corticosteroid injections. Guidelines lag behind the newest trials, and the 2025 meta-analysis above is more encouraging. But it means your doctor may reasonably suggest those first-line options before an investigational injection.

For a fuller, sourced review by condition, see our MSC research for orthopedic pain pillar.

See if you may be a candidate

Take a 2-minute assessment and we'll match you with a verified, board-certified clinic near you.

Take the Free Assessment

Severe or "bone-on-bone" arthritis

People with severe osteoarthritis are often the most interested in avoiding surgery, and they're the group with the least supporting evidence. Much of the stem cell research has focused on earlier-stage disease, and there is little evidence that an injection can help once cartilage is largely gone and the bones are rubbing together. For end-stage arthritis, joint replacement is a well-established and often highly effective option. If a clinic says an injection will fix bone-on-bone arthritis, be skeptical, and consider getting an opinion from an orthopedic surgeon as well.

Rheumatoid arthritis and stem cells

Rheumatoid arthritis (RA) is an autoimmune disease, so the research approach is different: stem cells are often given by IV to calm the immune system, rather than injected into one joint. A 2023 meta-analysis found only 4 controlled trials (358 patients). MSC treatment appeared safe, and disease activity scores trended better, but the improvement didn't hold beyond about 12 months without continued treatment. (Most of the authors work for a company that sells stem cell treatment, which is worth knowing when reading the conclusions.) For RA, stem cell therapy is best pursued through a clinical trial, alongside a rheumatologist, not as a replacement for proven medications.

What happens during a stem cell injection for arthritis

For osteoarthritis, the "procedure" is usually a single outpatient visit. If the clinic uses your own cells, they're first collected from bone marrow (usually the back of the hip) or fat, then concentrated on site. If it uses donor umbilical cord tissue, there's no collection step. The cells are then injected into the joint, ideally under ultrasound or X-ray guidance so they land in the right place. Most people go home the same day and return to light activity within a day or two. See what to expect during a stem cell treatment for the full step-by-step.

Who may be a candidate?

While only a licensed provider can confirm candidacy after reviewing your history and imaging, people who tend to explore stem cell therapy for arthritis include:

  • Adults with mild-to-moderate osteoarthritis in one or more joints
  • Those whose pain hasn't responded to physical therapy, medication, or prior injections
  • People who want to explore non-surgical options before considering joint replacement
  • Patients who aren't candidates for surgery, or who want to delay it

Certain conditions may make someone not a candidate — for example active cancer, active infection, or certain blood disorders. Advanced "bone-on-bone" arthritis may respond less well to injections than earlier-stage disease, and inflammatory/autoimmune arthritis should be managed with a rheumatologist.

Stem cell therapy vs. other arthritis treatments

vs. cortisone (corticosteroid) injections

Cortisone can reduce inflammation and provide short-term relief, but the effect often fades within weeks to months, and repeated use may have downsides for the joint over time. Regenerative approaches aim to support the joint environment rather than simply suppress inflammation — though they typically cost more and aren't covered by insurance.

vs. PRP (platelet-rich plasma)

PRP uses concentrated platelets from your own blood and is widely used for osteoarthritis, alongside or instead of stem cell therapy. It is generally less expensive. The best choice depends on your condition and the provider's assessment.

vs. joint replacement surgery

Compared with joint replacement, regenerative injections are minimally invasive with little downtime. Replacement is major surgery with a longer recovery — but for severe, end-stage arthritis it is a well-established and often highly effective option. The right choice depends entirely on your individual situation.

What does it cost?

Stem cell therapy for arthritis in the U.S. commonly ranges from roughly $3,000 to $10,000 per session, depending on the joint treated, cell source, provider, and whether more than one area is involved. Because many of these uses are still considered investigational, insurance usually does not cover them. Many clinics offer financing or payment plans. For a full breakdown, see our guide on how much stem cell therapy costs. For knee osteoarthritis specifically, our stem cell knee injection cost guide compares what four U.S. price studies found for one knee.

Questions to ask a provider

  • Is this treatment FDA-approved or investigational for my type and stage of arthritis?
  • What does the evidence suggest for someone with my joint and disease stage?
  • What cell source do you use, and how is it processed?
  • How many sessions might I need, and what's the total cost?
  • What results are realistic — and will you avoid promising cartilage regrowth or a cure?

Not sure where regulation stands? See our guide to whether stem cell therapy is FDA approved and safe.

Frequently asked questions

For knee osteoarthritis, the best current evidence shows it can modestly reduce pain and improve function for at least a year, based on a 2025 meta-analysis of 8 randomized trials. Evidence for the hip and shoulder is earlier-stage, and benefits for rheumatoid arthritis have not lasted beyond about 12 months. It is not FDA-approved for arthritis, it does not reliably regrow cartilage, and major osteoarthritis guidelines still recommend against stem cell injections.
Generally, no. The FDA states that regenerative products such as stem cells, exosomes, adipose-derived products, Wharton's jelly, cord blood, and amniotic fluid have not been approved to treat orthopedic conditions including osteoarthritis. The FDA-approved stem cell products are limited to cord blood cells for blood-production disorders and a few other cell products for blood cancers and transplant complications, none for orthopedic use. Use of stem cells for arthritis is considered investigational.
Research is still clarifying how much true cartilage regeneration occurs. Much of the observed benefit in studies is thought to come from the anti-inflammatory and signaling effects of mesenchymal stem cells rather than wholesale cartilage regrowth. Claims of guaranteed cartilage regeneration should be viewed skeptically.
Knee osteoarthritis has the most research to date. A 2025 meta-analysis of 8 randomized controlled trials (502 patients) found that stem cell injections improved knee pain and function at 6 and 12 months with no more side effects than control treatments, though the improvements were modest. Evidence for the hip, shoulder, and other joints is thinner.
The evidence is limited. A 2023 meta-analysis found only four controlled trials: stem cell treatment appeared safe and disease activity trended better, but the improvement did not last beyond about 12 months without continued treatment. Rheumatoid arthritis should be managed with a rheumatologist, and stem cell treatment is best pursued through a clinical trial rather than as a replacement for proven medications.
Usually not. Because most regenerative uses for arthritis are still considered investigational and not FDA-approved, insurers typically decline coverage. Ask the clinic for an itemized, out-of-pocket quote and about any financing options.

Not sure if you're a candidate?

Take a 2-minute assessment and we'll match you with a verified, board-certified clinic near you.

Take the Free Assessment

Related reading

  • Stem Cell Therapy for Knee Pain: What the Research Says
  • Stem Cell Therapy for Hip Pain
  • Stem Cell Therapy for Shoulder Pain
  • How Much Does Stem Cell Therapy Cost?
  • MSC Research for Orthopedic Pain
This article is for educational purposes only and is not medical advice. Stem cell therapy is not FDA-approved for all conditions, and individual results vary. Always consult a qualified healthcare provider about your specific situation.

Medical Disclaimer

The information provided on this website is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Stem cell therapy results vary by patient and are not guaranteed. Stem cell therapy is not FDA-approved for all conditions. Always consult with a qualified healthcare provider to discuss your specific medical situation and treatment options.


© 2026 Regenerative Treatment Guide. All rights reserved.

Talk to a clinic: (888) 540-7505 · Mon–Sat 8am–6pm ET

  • About Us
  • Conditions
  • Regenerative Medicine for Dogs
  • Locations
  • Blog
  • Cost & Financing
  • For Providers
  • Approved Providers
  • Podcast
  • FDA & Safety
  • FDA Warning Letters
  • Cost Calculator
  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Facebook
  • YouTube
  • LinkedIn